drugset / Trial / NCT02133534

The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease

NCT02133534 ↗

Phase 4 Terminated 1 enrolled Duke University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if patients with chronic kidney disease have endothelial cells that don't function properly, which is thought to be a marker for cardiovascular risk. Endothelial cells line the heart and blood vessels. The investigators will treat your high cholesterol with a cholesterol-lowering drug (atorvastatin, or Lipitor). They will determine if this cholesterol lowering drug improves subjects' cholesterol as well as the function of endothelial cells.

Timeline

Start
2008-02
Primary completion
2009-05
Completion
2009-05

Outcome

Outcome not reported

Stopped (Enrollment): “failure to enroll”

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —